Clinical Inquiries

Does furosemide decrease morbidity or mortality for patients with diastolic or systolic dysfunction?

Author and Disclosure Information

 

References

Recommendations from others

The American College of Cardiology recommends using diuretics in the setting of left ventricular systolic dysfunction and fluid retention (level of evidence [LOE]: A), and recommends using diuretics in diastolic dysfunction to control pulmonary congestion and peripheral edema (LOE: C).9

The European Society of Cardiology notes that no randomized controlled trials have assessed survival effects of diuretics in congestive heart failure, but recommends using diuretics for symptomatic treatment of volume overload (LOE: A). This society also cites evidence that diuretic use improves exercise tolerance (LOE: B). They recommend that diuretics be used always in addition to an ACE inhibitor, that loop diuretics be used if symptoms are more than mild and if glomerular filtration rate (GFR) <30 cc/min, and that thiazide diuretics can be used with loop diuretics for synergistic effects in severe congestive heart failure. 10

Clinical Commentary

Helpful in the acute setting, diuretics shouldn’t be used alone chronically
Jon Neher, MD
Valley Medical Center, Renton, Wash

Furosemide and the other loop diuretics are very satisfying to use clinically. The patient in heart failure arrives at the hospital dypsneic, cyanotic, and terrified. After a single large dose of medication, the patient diureses and begins to feel good again quite quickly.

The practitioner, however, needs to be wary of the resulting impression that diuretics are “good” for heart failure. ACE inhibitors, beta blockers, and (in severe cases) spironolactone are “good” for heart failure because they prolong lives. One must not allow diuretic therapy—started for acute decompensation— to prevent use of more important long-term medications by causing dehydration, hypotension, or electrolyte disturbances.

Pages

Evidence-based answers from the Family Physicians Inquiries Network

Recommended Reading

Conivaptan Reverses Hyponatremia, Studies Show
MDedge Family Medicine
Low Relative Lymphocyte Count Flags Cardiomyopathy Risk
MDedge Family Medicine
Bare-Metal Stents Match Bypass in 5-Year Mortality
MDedge Family Medicine
Prior Oxygen Boost May Aid Post-CABG Cognition
MDedge Family Medicine
Cardiovascular Risks Rising in Native Americans
MDedge Family Medicine
Late Thrombosis Haunts Drug-Eluting Stents
MDedge Family Medicine
Drug-Eluting Stents Meet Cost-Effectiveness Standards
MDedge Family Medicine
Natural Supplements Can Help Lower Lipids
MDedge Family Medicine
Poor Kidney Function Augurs Anemia in HF
MDedge Family Medicine
Encouraging Results From New Platelet Inhibitor
MDedge Family Medicine